Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Improving Your Bottom Line: Is Your Practice Prepared for a Disaster?
Owen Dahl, Owen Dahl Consulting
Today's Oncology News: MCF2, A New Mitotic Checkpoint Control Point
D Scott Cunningham MD, PhD, MDLinx Oncology
Clinical Trial Watch: Trial Points to Cancer-Fighting Potential of IL-7
Tracy Hampton, PhD, MDLinx Oncology
  See all
breast cancer;high insulin levels Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome
Breast Cancer Research and Treatment, 05/16/08
Print     Email This Article     Save in My Library   Free Abstract
Goodwin PJ et al. – High insulin levels in locoregional breast cancer indicate insulin resistance and are associated with other components of insulin resistance syndrome (IRS); development of therapies targeting hyperinsulinemia in early stage breast cancer may be useful in long-term management of breast cancer survivors

Methods

  • Study of possible association of hyperinsulinemia with insulin resistance in a cohort of newly diagnosed locoregional breast cancer pts and associations of hyperinsulinemia with broader IRS
  • Glucose, insulin, and lipid analysis in fasting blood of 504 pts with T1-3, N0-1, M0 breast cancer
  • Review of pt anthropomorphic measurements and diet, exercise, sleep data
  • Review of relationships of insulin with 3 validated indices of insulin resistance and with IRS attributes

Results
  • High insulin levels correlated strongly with insulin resistance calculated using 3 indices of insulin resistance/sensitivity
  • Hyperinsulinemia associated with other IRS components: obesity, high waist–hip ratio, lipid profile

 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

--- BREAST TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- ENDOCRINE ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.